Modeling the course of amyotrophic lateral sclerosis

Large-scale computational analysis of patient data leads to better models of disease progression.

[1]  J. Glass.  New drugs for ALS: How do we get there? , 2012, Experimental Neurology.

[2]  C. Arteaga,et al.  New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available , 2011, Clinical Cancer Research.

[3]  M. Cudkowicz,et al.  The PRO-ACT database , 2014, Neurology.

[4]  M. Cudkowicz,et al.  Scrutinizing enrollment in ALS clinical trials: Room for improvement? , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[5]  Johann S. Hawe,et al.  Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression , 2014, Nature Biotechnology.